Nitric Oxide Synthase Dysfunction Contributes to Impaired Cerebroarteriolar Reactivity in Experimental Cerebral Malaria

PLoS Pathogens

Volumn 9, Issue 6, 2013, Pages

  Ong, Peng Kai ^a   Melchior, Benoît ^a   Martins, Yuri C ^a   Hofer, Anthony ^a   Orjuela Sánchez, Pamela ^a   Cabrales, Pedro ^b   Zanini, Graziela M ^a,c   Frangos, John A ^a   Carvalho, Leonardo J M ^a,d  

^a LA JOLLA BIOENGINEERING INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Funda??o Oswaldo Cruz   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N (G) METHYLARGININE; N METHYL DEXTRO ASPARTIC ACID; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; BRAIN MALARIA; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HYPOTHERMIA; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARASITEMIA; PHOSPHORYLATION; PIA ARTERY; PROTEIN EXPRESSION; SCORING SYSTEM; SIGNAL TRANSDUCTION; UPREGULATION; VASODILATATION; WESTERN BLOTTING;

ACETYLCHOLINE; ANIMALS; BIOPTERIN; CEREBROVASCULAR CIRCULATION; CHOLINERGIC AGONISTS; EXCITATORY AMINO ACID AGONISTS; FEMALE; MALARIA, CEREBRAL; MICE; MICROCIRCULATION; N-METHYLASPARTATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; PLASMODIUM BERGHEI;

MUS; PLASMODIUM BERGHEI;

EID: 84879530207     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003444     Document Type: Article

References (55)

1. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413-431.
2. de Souza JB, Hafalla JC, Riley EM, Couper KN, (2010) Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 137: 755-772.
3. White NJ, Turner GD, Medana IM, Dondorp AM, Day NP, (2010) The murine cerebral malaria phenomenon. Trends Parasitol 26: 11-15.
4. Carvalho LJ, (2010) Murine cerebral malaria: how far from human cerebral malaria? Trends Parasitol 26: 271-272.
5. Stevenson MM, Gros P, Olivier M, Fortin A, Serghides L, (2010) Cerebral malaria: human versus mouse studies. Trends Parasitol 26: 274-275.
6. Riley EM, Couper KN, Helmby H, Hafalla JC, de Souza JB, et al. (2010) Neuropathogenesis of human and murine malaria. Trends Parasitol 26: 277-278.
7. Desruisseaux MS, Machado FS, Weiss LM, Tanowitz HB, Golightly LM, (2010) Cerebral malaria: a vasculopathy. Am J Pathol 176: 1075-1078.
8. Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ, (2010) Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am J Pathol 176: 1306-1315.
9. Toda N, Ayajiki K, Okamura T, (2009) Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev 61: 62-97.
10. Reis PA, Comim CM, Hermani F, Silva B, Barichello T, et al. (2010) Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Path 6: e1000963.
11. Rae C, McQuillan JA, Parekh SB, Bubb WA, Weiser S, et al. (2004) Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria. FASEB J 18: 499-510.
12. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL, (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93: 6770-6774.
13. Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ, (2011) Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology. J Infect Dis 203: 1454-1463.
14. Zanini GM, Martins YC, Cabrales P, Frangos JA, Carvalho LJ, (2012) S-nitrosoglutathione prevents experimental cerebral malaria. J Neuroimmune Pharmacol 7: 477-487.
15. Miller LH, Baruch DI, Marsh K, Doumbo OK, (2002) The pathogenic basis of malaria. Nature 415: 673-679.
16. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE, (2006) A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 22: 503-508.
17. Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, et al. (2006) Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med 12: 1417-1422.
18. Forstermann U, Sessa WC, (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33: 829-837d, 829-837, 837a-837d.
19. Fleming I, Busse R, (2003) Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284: R1-12.
20. Sanchez-Blazquez P, Rodriguez-Munoz M, Garzon J, (2010) Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling. PLoS One 5: e11278.
21. Zhang QJ, McMillin SL, Tanner JM, Palionyte M, Abel ED, et al. (2009) Endothelial nitric oxide synthase phosphorylation in treadmill-running mice: role of vascular signalling kinases. J Physiol 587: 3911-3920.
22. Srivastava K, Bath PM, Bayraktutan U, (2012) Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke. Cell Mol Neurobiol 32: 319-336.
23. Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, et al. (2007) Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci U S A 104: 15081-15086.
24. Medana IM, Mai NT, Day NP, Hien TT, Bethell D, et al. (2001) Cellular stress and injury responses in the brains of adult Vietnamese patients with fatal Plasmodium falciparum malaria. Neuropathol Appl Neurobiol 27: 421-433.
25. Kietadisorn R, Juni RP, Moens AL, (2012) Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metabol 302: E481-495.
26. Youn JY, Gao L, Cai H, (2012) The p47(phox)- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia 55: 2069-2079.
27. Cunnington C, Van Assche T, Shirodaria C, Kylintireas I, Lindsay AC, et al. (2012) Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation 125: 1356-1366.
28. Porkert M, Sher S, Reddy U, Cheema F, Niessner C, et al. (2008) Tetrahydrobiopterin: a novel antihypertensive therapy. J Hum Hypertens 22: 401-407.
29. Zhen J, Lu H, Wang XQ, Vaziri ND, Zhou XJ, (2008) Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens 21: 28-34.
30. Bendall JK, Alp NJ, Warrick N, Cai S, Adlam D, et al. (2005) Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res 97: 864-871.
31. Zou MH, Shi C, Cohen RA, (2002) Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826.
32. Kotsonis P, Frohlich LG, Shutenko ZV, Horejsi R, Pfleiderer W, et al. (2000) Allosteric regulation of neuronal nitric oxide synthase by tetrahydrobiopterin and suppression of auto-damaging superoxide. Biochem J 346 Pt 3: 767-776.
33. Cabrales P, Carvalho LJ, (2010) Intravital microscopy of the mouse brain microcirculation using a closed cranial window. J Vis Exp 45: e2184.
34. Chalupsky K, Cai H, (2005) Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 102: 9056-9061.
35. Bevers LM, Braam B, Post JA, van Zonneveld AJ, Rabelink TJ, et al. (2006) Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension 47: 87-94.
36. Forstermann U, Munzel T, (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714.
37. Claser C, Malleret B, Gun SY, Wong AY, Chang ZW, et al. (2011) CD8+ T cells and IFN-gamma mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One 6: e18720.
38. Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, van Rooijen N, et al. (2002) On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol 169: 6369-6375.
39. Kubes P, Suzuki M, Granger DN, (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 88: 4651-4655.
40. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, et al. (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60-68.
41. Zanini GM, Cabrales P, Barkho W, Frangos JA, Carvalho LJ, (2011) Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice. J Neuroinflammation 8: 66.
42. Yalcin O, Ulker P, Yavuzer U, Meiselman HJ, Baskurt OK, (2008) Nitric oxide generation by endothelial cells exposed to shear stress in glass tubes perfused with red blood cell suspensions: role of aggregation. Am J Physiol Heart Circ Physiol 294: H2098-2105.
43. Yang YM, Huang A, Kaley G, Sun D, (2009) eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol 297: H1829-1836.
44. Sanchez A, Contreras C, Martinez MP, Climent B, Benedito S, et al. (2012) Role of neural NO synthase (nNOS) uncoupling in the dysfunctional nitrergic vasorelaxation of penile arteries from insulin-resistant obese Zucker rats. PLoS One 7: e36027.
45. Takaya T, Hirata K, Yamashita T, Shinohara M, Sasaki N, et al. (2007) A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression. Arterioscler Thromb Vasc Biol 27: 1632-1637.
46. Martins YC, Zanini GM, Frangos JA, Carvalho LJ, (2012) Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA. PLoS One 7: e32048.
47. Siow RC, Richards JP, Pedley KC, Leake DS, Mann GE, (1999) Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler Thromb Vasc Biol 19: 2387-2394.
48. Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell RW, et al. (1996) Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta. Br J Pharmacol 118: 1359-1366.
49. Machado FS, Desruisseaux MS, Nagajyothi, Kennan RP, Hetherington HP, et al. (2006) Endothelin in a murine model of cerebral malaria. Exp Biol Med 231: 1176-1181.
50. Dietmann A, Lackner P, Helbok R, Spora K, Issifou S, et al. (2008) Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar J 7: 253.
51. Pardridge WM, (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics 2: 3-14.
52. Fukai T, (2007) Endothelial GTPCH in eNOS uncoupling and atherosclerosis. Arterioscler Thromb Vasc Biol 27: 1493-1495.
53. Martins YC, Smith MJ, Pelajo-Machado M, Werneck GL, Lenzi HL, et al. (2009) Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA. Int J Exp Pathol 90: 119-130.
54. Melchior B, Frangos JA, (2012) Galphaq/11-mediated intracellular calcium responses to retrograde flow in endothelial cells. Am J Physiol Cell Physiol 303: C467-473.
55. Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF, et al. (1994) Resistance to blood flow in microvessels in vivo. Circ Res 75: 904-915.